David J. Maloney

Dr. Dave Maloney is a scientifically trained leader with 10 years of experience in drug discovery and development performed at the NIH’s National Center for Advancing Translational Sciences (NCATS). He was a Group Leader in Chemistry and co-led an interdisciplinary project team during his tenure at NCATS. During this time, Dr. Maloney led a team of senior scientists in lead-identification and late-stage lead optimization efforts resulting in identification and development of Veralox’s lead product candidate. He managed a project portfolio encompassing a broad range of therapeutic areas and target classes which involved close collaboration and interaction with leading researchers from around the world in both academia and the private sector. During that time, he coordinated and managed R&D efforts with domestic and international CROs to advance projects in an efficient manner. Dr. Maloney is co-author on over 100 scientific publications and co-inventor on more than 10 composition of matter patents. He earned a Bachelor of Science in Chemistry from the University of Vermont and a Doctor of Philosophy in Organic Chemistry from the University of Virginia. Following completion of his PhD, Dr. Maloney was a Postdoctoral Fellow at Memorial Sloan-Kettering Cancer Center. He has served as an ad hoc reviewer for the Defense Threat Reduction Agency (DTRA) and National Institute of Allergy and Infectious Diseases (NIAID) and frequently is an invited reviewer of scientific manuscripts for multiple medicinal chemistry focused journals.